Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells
- Author(s)
- Thijssen, R; Alvarez-Diaz, S; Grace, C; Gao, MY; Segal, DH; Xu, Z; Strasser, A; Huang, DCS;
- Journal Title
- Cell Death and Differentiation
- Publication Type
- Journal epub ahead of print
- Publisher
- NPG
- Research Division(s)
- Blood Cells And Blood Cancer
- PubMed ID
- 32555451
- Publisher's Version
- https://doi.org/10.1038/s41418-020-0576-2
- Open Access at Publisher's Site
https://doi.org/10.1038/s41418-020-0576-2- NHMRC Grants
- NHMRC/1016701, NHMRC/1020363,
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2020-06-22 11:52:57
Last Modified: 2020-06-22 03:56:50